As part of the Roadmap for the reform of medicine reimbursement procedures (here and here), an important piece of the healthcare section of the governmental agreement
Today, the Belgian Competition Authority (BCA) accused the Roche group of having implemented a strategy between 2017 and 2020 designed to delay the market entry
On 13 February 2025, the Court of First Instance of Rotterdam (Rechtbank Rotterdam – the Court) largely confirmed the decision of the Dutch competition authority
On 10 February 2025, the Swiss medicines agency, Swissmedic, and the Swiss Association of Research Ethics Committees, Swissethics, issued an updated version of their position paper on decentralised clinical trials